Patent intelligence · WO
WO 2025214466
CONJUGUÉS DE PYRROLOBENZODIAZÉPINE CIBLÉS
CONJUGUÉS DE PYRROLOBENZODIAZÉPINE CIBLÉS
Patent details — WO 2025214466
- Jurisdiction
- WO
- Status
- granted
- Grant date
- Oct 16, 2025
- Expiration
- Oct 11, 2045
- CPC classes
- A61K/4768035, A61K/476849, A61K/476889
Quick answer
WO 2025214466 (CONJUGUÉS DE PYRROLOBENZODIAZÉPINE CIBLÉS) is held by BEIGENE GUANGZHOU BIOLOGICS MFG CO LTD [CN]. Status: granted. Granted Oct 16, 2025. Expires Oct 11, 2045 (19 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Grant date
- Expiration
- Claims
- —
- CPC classes
- A61K/4768035, A61K/476849, A61K/476889
More from BEIGENE GUANGZHOU BIOLOGICS MFG CO LTD [CN]
Related pharmaceutical patents in our USPTO index.
-
WO 2025252204
DISPERSIONS SOLIDES AMORPHES D'UN INHIBITEUR DE BRAF
granted -
AU 2025242171
A Medicament and Method of Treatment of Central Nervous System and/or Neuropsychiatric Disorders
granted -
WO 2025232885
PROCÉDÉ DE PRÉPARATION D'UN AGENT DE DÉGRADATION DE LA TYROSINE KINASE DE BRUTON
granted -
WO 2025218772
FORMES SOLIDES COMPRENANT UN AGENT DE DÉGRADATION DE TYROSINE KINASE DE BRUTON ET LEURS UTILISATIONS
granted -
WO 2025201453
COMPOSÉS MACROCYCLIQUES UTILISÉS EN TANT QU'INHIBITEURS DE RAS
granted -
US 2025304535
KAT6 Inhibitors
granted -
US 2025290040
GAMMA DELTA T CELL COMPOSITIONS AND METHODS OF USE
granted
Frequently asked questions
What is US patent 2025214466?
WO 2025214466 (CONJUGUÉS DE PYRROLOBENZODIAZÉPINE CIBLÉS) is held by BEIGENE GUANGZHOU BIOLOGICS MFG CO LTD [CN]. Status: granted. Granted Oct 16, 2025. Expires Oct 11, 2045 (19 years remaining) — relevant for patent-cliff and LOE planning.
Who owns WO 2025214466?
BEIGENE GUANGZHOU BIOLOGICS MFG CO LTD [CN] is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 25 pharmaceutical patents for this assignee.
When does WO 2025214466 expire?
Our index shows an expiration date of Oct 11, 2045 (19 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.